1Bacci G,Longhi A,Fagioli F,et al.Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities:27 year experience at Rizzoli Institute,Italy[J].Eur J Cancer,2005,41(18):2836-2845.
4Meyers PA,Schwartz CL,Krailo MD,et al.Osteosarcoma:the addition of muramyl tripeptide to chemotherapy improves overall survival:a report from the Children's Oncology Group[J].J Clin Oncol,2008,26(4):633-638.
5Longhi A,Ferrari S,Bacci G,et al.Long-erm follow-p of patients with doxorubicin-nduced cardiac toxicity after chemotherapy for osteosarcoma[J].Anticancer Drugs,2007,18(6):737-744.
6Lewis IJ,Nooij MA,Whelan J,et al.Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy:a randomized phase III trial of the European Osteosarcoma Intergroup[J].J Natl Cancer Inst,2007,99(2):112-128.
8Goorin AM,Schwartzentruber DJ,Devidas M,et al.Presurgical chemotherapy compared with immediate surgery and adjuvant che-motherapy for nonmetastatic osteosarcoma:Pediatric Oncology Group Study POG-8651[J].J Clin Oncol,2003,21(8):1574-1580.
9Bacci G,Mercuri M,Longhi A,et al.Grade of chemotherapy-nduced necrosis as a predictor of local and systemic control in 881 patients with non梞etastatic osteosarcoma of the extremities treated with neoadjuvant chemodierapy in a single institution!]].Eur J Cancer,2005,41(14):2079-2085.
10Marina N,Bielack S,WhelanJ,et al.International collaboration is feasible in trials for rare conditions:the EURAMOS exprience[J].Cancer Treat Res,2009,152:339-353.
二级参考文献4
1Enneking WF,Spanier SS,Goodman MA.A system for the surgical staging of musculoskeletal sarcoma.Clin Orthop,1980,(153):106-120.
2Enneking WF,Dunham W,Gebhardt MC.A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system.Clin Orthop,1993,(286):241-248.
3Bacci G,Forni C,Ferrari S.Neoadjuvant chemotherapy for osteosarcoma of the extremity:intensification of preoperative treatment does not increase the rate of good histologic response to the primary tumor or improve the final outcome.J Pediatr Hematol Oncol,2003,25:845-853.
6Benjamin RS,Patel SR. Pediatric and adult osteosarcoma:comparisons and contrasts in presentation and therapy[J].{H}Cancer Treat Research,2009.355-363.
7Pakos EE,Nearchou AD,Grimer RJ. Prognostic fac-tors and outcomes for osteosarcoma:an international collab-oration[J].{H}EUROPEAN JOURNAL OF CANCER,2009,(13):2367-2375.
8Gupta GR,Yasko AW,Lewis VO. Risk of local recur-rence after deltoid-sparing resection for osteosarcoma of the proximal humerus[J].{H}CANCER,2009,(16):3767-3773.
9Sakamoto A,Iwamoto Y. Current status and perspectives re-garding the treatment of osteo-sarcoma:chemotherapy[J].Rev Recent Clin Trials,2008,(03):228-231.
